Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOUT study: Short-course antibiotics vs single-dose fosfomycin trometamol for uncomplicated lower urinary tract infection in adult women
2021-001332-26Phase 4Active
- Sponsor
- IDIAPJGol
- Start
- Jul 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nitrofurantoin, pivmecillinam and fosfomycin in urinary tract infection (UTI) (4 arms), sponsored by IDIAPJGol. Primary endpoints: Clinical effectiveness and Bacteriological eradication. Started Jul 2021; status: active.
02
Drugs
nitrofurantoinpivmecillinamfosfomycin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2021-001332-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001332-26.